Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter Beitsch, MD
Dallas Surgical Group
Principal Investigator - Rakesh Patel, MD
University of Wisconsin Radiation Oncology Department
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dch Cancer Treatment Center
Tuscaloosa, Alabama, United States
- Beverly Oncology
Montebello, California, United States
- Florida Radiation Oncology Group
Orange Park, Florida, United States
- St Elizabeth'S and Memorial Cancer Center
Swansea, Illinois, United States
- Cancer Institute of Cape Girardeau
Cape Girardeau, Missouri, United States
- Atlanticare Cancer Care Institute
Galloway, New Jersey, United States
- Nazha Cancer Center
Northfield, New Jersey, United States
- Dallas Surgical Group / Northpoint Cancer Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 31 Jan 2015
- Completion
- 31 Jan 2015
- Last update posted
- 17 May 2016
- Registered enrollment
- 63
- Registry id
- NCT00742222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.